These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1295502)

  • 21. Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.
    Omland T
    Scand J Clin Lab Invest Suppl; 2005; 240():18-24. PubMed ID: 16112956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
    Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
    Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal pro-B-type natriuretic peptides in stable and unstable ischemic heart disease.
    Omland T; de Lemos JA
    Am J Cardiol; 2008 Feb; 101(3A):61-6. PubMed ID: 18243861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology of acute coronary syndromes].
    Ogawa H
    J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma level changes of fibrinopeptide A after uncomplicated coronary angioplasty.
    Manolis AS; Melita-Manolis H; Stefanadis C; Toutouzas P
    Clin Cardiol; 1993 Jul; 16(7):548-52. PubMed ID: 8348763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procoagulant and proinflammatory activity in acute coronary syndromes.
    Manten A; de Winter RJ; Minnema MC; ten Cate H; Lijmer JG; Adams R; Peters RJ; van Deventer SJ
    Cardiovasc Res; 1998 Nov; 40(2):389-95. PubMed ID: 9893733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain.
    Sonel A; Sasseen BM; Fineberg N; Bang N; Wilensky RL
    Circulation; 2000 Sep; 102(10):1107-13. PubMed ID: 10973838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
    Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
    Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary artery thrombus formation in unstable angina: a clinical, biochemical and angiographic correlation.
    Wilensky RL; Bourdillon PD; Vix VA; Zeller JA
    J Am Coll Cardiol; 1993 Mar; 21(3):692-9. PubMed ID: 8436751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinopeptide A levels in patients with acute ischaemic heart disease.
    Pacchiarini L; Storti C; Zucchella M; Salerno JA; Grignani G; Fratino P
    Haemostasis; 1989; 19(3):147-51. PubMed ID: 2744631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a commercial kit for the radioimmunoassay of fibrinopeptide A.
    Butt RW; deBoer AC; Turpie AG
    J Immunoassay; 1984; 5(3-4):245-66. PubMed ID: 6530485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease?
    Gallino A; Häberli A; Straub PW; Steinbrunn W; Turina M; Rothlin ME
    Eur Heart J; 1987 Jul; 8(7):734-7. PubMed ID: 2958280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinopeptide A: a marker of acute coronary thrombosis.
    Eisenberg PR; Sherman LA; Schectman K; Perez J; Sobel BE; Jaffe AS
    Circulation; 1985 May; 71(5):912-8. PubMed ID: 3986981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary fibrinopeptide A levels in ischemic heart disease.
    Wilensky RL; Zeller JA; Wish M; Tulchinsky M
    J Am Coll Cardiol; 1989 Sep; 14(3):597-603. PubMed ID: 2768709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study.
    Neri Serneri GG; Gensini GF; Carnovali M; Prisco D; Rogasi PG; Casolo GC; Fazi A; Abbate R
    Am Heart J; 1987 Mar; 113(3):672-8. PubMed ID: 3825856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased protein C and fibrinopeptide A concentration in patients with angina.
    Gensini GF; Rostagno C; Abbate R; Favilla S; Mannucci PM; Neri Serneri GG
    Thromb Res; 1988 May; 50(4):517-25. PubMed ID: 3413718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
    Gallino A; Haeberli A; Straub PW
    Thromb Res; 1985 Jul; 39(2):237-44. PubMed ID: 4024054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is raised plasma fibrinopeptide A a marker of acute coronary insufficiency?
    Neri Serneri GG; Gensini GF; Abbate R; Laureano R; Parodi O
    Lancet; 1980 Nov; 2(8201):982-3. PubMed ID: 6107625
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic role of hemostatic markers in acute coronary syndromes patients.
    Ottani F; Galvani M
    Clin Chim Acta; 2001 Sep; 311(1):33-9. PubMed ID: 11557250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.